Purpose
to evaluate the safety and immune responses elicited by a candidate COVID-19 vaccine in the South African population including but not limited to individuals living with HIV
Grantee
Division
Global Health
Date
JUNE 2020
Region served
AFRICA
Committed amount
$13,687,347
Grant topic
HIV,
Pneumonia & Pandemic Preparedness
Duration (months)
43
Grantee location
Johannesburg, GP, South Africa
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.